A Safety, Tolerability, and Pharmacokinetic Study of NIP292 in Healthy Normal Subjects
A Phase 1, Two-Part Study of NIP292 Tablets in Healthy Adult Subjects: Part 1 - Randomized, Double-Blind, Placebo-Controlled Assessment of Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses; Part 2 - Randomized, Double-Blind, Placebo-Controlled Assessment of Safety, Tolerability and Pharmacokinetics of Multiple Ascending Oral Doses. A Phase 1, Two-Part Study of NIP292 Tabletsin Healthy Adult Subjects: Part 1 - Randomized, Double-Bl ...
Idiopathic Pulmonary Fibrosis
Drug: NIP292 tablet;Drug: NIP292 tablets
The National Institutes of Pharmaceutical R&D Co. Ltd, China